文献速递慢性肾脏病遗传性与小管间质肾病

人工智能自动算法测量常染色体显性多囊肾病总肾脏体积

An Artificial Intelligence Generated Automated Algorithm to Measure Total Kidney Volume in ADPKD.
PubMed 文献 · Kidney Int Rep · 2023-11-04

本研究开发并验证了一种基于集成U-net算法的人工智能工具,用于常规测量常染色体显性多囊肾病(ADPKD)患者的总肾脏体积(TKV)。在训练和内部交叉验证队列(227次1.5T MRI扫描)及独立临床验证队列(48次临床MRI扫描)中,算法与人工分割的median DICE评分为0.96,median TKV误差为-1.8%。该算法性能与人工分割相当,且手动修正时间显著缩短,适合临床应用。

要点

  • AI算法测量TKV与人工分割高度一致,median DICE评分0.96。
  • 临床验证中median TKV误差仅-1.8%,精度高。
  • 算法输出手动修正时间8.5分钟,远低于人工分割的56分钟。

核心结论

  • AI算法在ADPKD患者TKV测量中性能与人工分割相当,具有快速精准的特点,适合临床常规应用。

研究设计与样本

  • 采用nnUNet方法构建集成U-net算法,训练和内部交叉验证队列为CYSTic联盟的227次1.5T MRI扫描(454个肾脏),由单一操作者手动分割。
  • 独立临床验证队列为单中心48次连续临床MRI扫描,参考结果为6名分析员手动分割。

主要发现

  • 训练或内部验证队列较临床验证队列年轻(平均年龄44.0 vs 51.5岁),女性与男性比例更高(1.2 vs 0.94)。
  • CYSTic患者多数有PKD1突变(79%)和典型疾病(Mayo影像分类1类,86%)。
  • 临床验证数据集中算法与人工分析员的median DICE评分左右肾均为0.96,median TKV误差为-1.8%。
  • CYSTic数据集中手动分割肾脏耗时56(±28)分钟,而算法输出手动修正每次扫描耗时8.5(±9.2)分钟。

临床怎么用

  • 该AI工具可用于临床常规测量ADPKD患者TKV,快速获得结果并仅需少量手动修正,有助于个体化预后评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Accurate tools to inform individual prognosis in patients with autosomal dominant polycystic kidney disease (ADPKD) are lacking. Here, we report an artificial intelligence (AI)-generated method for routinely measuring total kidney volume (TKV). METHODS: An ensemble U-net algorithm was created using the nnUNet approach. The training and internal cross-validation cohort consisted of all 1.5T magnetic resonance imaging (MRI) data acquired using 5 different MRI scanners (454 kidneys, 227 scans) in the CYSTic consortium, which was first manually segmented by a single human operator. As an independent validation cohort, we utilized 48 sequential clinical MRI scans with reference results of manual segmentation acquired by 6 individual analysts at a single center. The tool was then implemented for clinical use and its performance analyzed. RESULTS: The training or internal validation cohort was younger (mean age 44.0 vs. 51.5 years) and the female-to-male ratio higher (1.2 vs. 0.94) compared to the clinical validation cohort. The majority of CYSTic patients had PKD1 mutations (79%) and typical disease (Mayo Imaging class 1, 86%). The median DICE score on the clinical validation data set between the algorithm and human analysts was 0.96 for left and right kidneys with a median TKV error of -1.8%. The time taken to manually segment kidneys in the CYSTic data set was 56 (±28) minutes, whereas manual corrections of the algorithm output took 8.5 (±9.2) minutes per scan. CONCLUSION: Our AI-based algorithm demonstrates performance comparable to manual segmentation. Its rapidity and precision in real-world clinical cases demonstrate its suitability for clinical application.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Taylor J, Thomas R, Metherall P, et al. An Artificial Intelligence Generated Automated Algorithm to Measure Total Kidney Volume in ADPKD. Kidney Int Rep. 2023. PMID: 38344736. doi:10.1016/j.ekir.2023.10.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。